'Serious injury or death'
The WHO alert said an analysis of the syrup samples by the quality control laboratories of Uzbekistan found "unacceptable amounts of diethylene glycol and/or ethylene glycol as contaminants"."Both of these products may have marketing authorisations in other countries in the region. They may also have been distributed, through informal markets, to other countries or regions," WHO said.
The products were "unsafe and their use, especially in children, may result in serious injury or death", it said.It is the second Indian drugmaker to face a probe by regulators since October, when the WHO linked another firm's medicines to a spate of child deaths in Gambia. Maiden Pharmaceuticals was accused of manufacturing several toxic cough and cold remedies that led to the deaths of at least 66 children in the African country.India launched a probe into Maiden Pharmaceuticals but later said the investigation had found the suspect drugs were of "standard quality".